Could heart failure with reduced ejection fraction be causing the hypoxia and hemoptysis in a 67‑year‑old woman?

Could HFrEF Be Causing Hypoxia and Hemoptysis in a 67-Year-Old Woman?

HFrEF is an unlikely primary explanation for hemoptysis in this patient, though it could contribute to hypoxia through pulmonary congestion. While heart failure with reduced ejection fraction can cause respiratory symptoms, hemoptysis is not a typical presenting feature and should prompt investigation for alternative or coexisting pulmonary pathology. 1

Why HFrEF Is Less Likely as the Primary Diagnosis

Epidemiologic Considerations in Women

• HFrEF is significantly less common in women aged 67 years compared to men, with women far more likely to develop heart failure with preserved ejection fraction (HFpEF). 1
• Women develop heart failure at an older age than men, and when they do, the etiology is more commonly hypertensive or valvular disease rather than ischemic cardiomyopathy. 1
• In this age group, if heart failure is present, the ejection fraction is statistically more likely to be preserved (≥50%) rather than reduced (≤40%). 1

Hemoptysis Is Not a Characteristic Feature of HFrEF

• The classic presentation of HFrEF includes dyspnea, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, and exertional limitation—not hemoptysis. 1, 2
• While severe acute decompensated heart failure can rarely cause pink frothy sputum from pulmonary edema, frank hemoptysis suggests alternative diagnoses such as pulmonary embolism, malignancy, infection, or pulmonary hypertension. 1

When to Consider HFrEF in the Differential

Diagnostic Criteria That Must Be Met

• HFrEF requires both clinical symptoms of heart failure AND documented left ventricular ejection fraction ≤40% on echocardiography. 1, 2, 3
• Elevated natriuretic peptides support the diagnosis: BNP >35 pg/mL (outpatient) or >100 pg/mL (hospitalized); NT-proBNP >125 pg/mL (outpatient) or >300 pg/mL (hospitalized). 1, 4
• Physical examination findings should include evidence of volume overload: jugular venous distension, pulmonary rales, S3 gallop, and peripheral edema. 1

Hypoxia Mechanisms in HFrEF

• If HFrEF is present, hypoxia results from pulmonary venous congestion causing interstitial and alveolar edema, which impairs gas exchange. 1
• Reduced cardiac output in HFrEF leads to decreased arteriovenous oxygen difference, which accounts for >50% of the reduction in peak VO₂ and contributes to tissue hypoxia. 5
• Pulmonary hypertension develops in 52-83% of patients with heart failure (more commonly HFpEF than HFrEF) and can cause right ventricular dysfunction, further compromising oxygenation. 1, 5

Alternative Diagnoses to Prioritize

Pulmonary Hypertension

• Pulmonary hypertension has a female-to-male ratio of 1.8:1 overall and 4:1 for pulmonary arterial hypertension specifically, making it more common in women. 1
• Pulmonary hypertension can cause hemoptysis and hypoxia and should be evaluated with echocardiography and right heart catheterization if suspected. 1

HFpEF With Pulmonary Complications

• Given this patient's age and sex, HFpEF (LVEF ≥50%) is statistically more probable than HFrEF. 1
• HFpEF can cause pulmonary congestion and hypoxia but, like HFrEF, does not typically present with hemoptysis. 1, 4
• HFpEF diagnosis requires symptoms plus LVEF ≥50% plus objective evidence of elevated filling pressures (elevated natriuretic peptides, E/e′ ≥15, left atrial enlargement, or invasive hemodynamics). 1, 4

Other Critical Considerations

• Takotsubo cardiomyopathy is particularly prevalent in postmenopausal women (mean age 66.8 years, 90% female) and causes sudden, severe but reversible left ventricular dysfunction. 1
• Acute pulmonary embolism can cause both hemoptysis and hypoxia and may precipitate acute right ventricular failure. 1
• Malignancy, tuberculosis, bronchiectasis, and pulmonary arteriovenous malformations must be excluded in any patient presenting with hemoptysis. 1

Diagnostic Algorithm for This Patient

Step 1: Confirm Heart Failure Diagnosis

• Obtain transthoracic echocardiography to measure LVEF, assess diastolic function, evaluate for valvular disease, and estimate pulmonary artery pressures. 1, 4
• Measure BNP or NT-proBNP to support or refute heart failure diagnosis. 1, 4
• If LVEF is ≤40%, HFrEF is confirmed; if LVEF is 41-49%, classify as HFmrEF; if LVEF is ≥50%, consider HFpEF. 1, 6

Step 2: Investigate Hemoptysis Etiology

• Obtain chest CT angiography to evaluate for pulmonary embolism, malignancy, bronchiectasis, and parenchymal lung disease. 1
• Perform bronchoscopy if imaging is non-diagnostic and hemoptysis persists. 1
• Do not attribute hemoptysis to heart failure without excluding other causes, as this is not a typical manifestation. 1

Step 3: Assess for Pulmonary Hypertension

• If echocardiography suggests elevated pulmonary artery systolic pressure (>35-40 mmHg), consider right heart catheterization to confirm pulmonary hypertension and differentiate pre-capillary from post-capillary causes. 1, 5
• Pulmonary hypertension secondary to left heart disease (Group 2 PH) is the most common form and can occur with either HFrEF or HFpEF. 1, 5

Common Pitfalls to Avoid

• Do not assume HFrEF based on symptoms alone without echocardiographic confirmation of reduced ejection fraction. 1, 2
• Do not overlook HFpEF in elderly women, as it is the predominant heart failure phenotype in this demographic. 1, 4
• Do not attribute hemoptysis to heart failure without thorough investigation for alternative pulmonary pathology. 1
• Natriuretic peptide levels may be modestly elevated or even normal in HFpEF, especially in obese patients, so borderline values should not exclude the diagnosis. 4
• Central sleep apnea with Cheyne-Stokes breathing (CSA-HCSB) can occur in HFrEF and presents with insomnia, fatigue, and occasionally orthopnea, but this is a consequence rather than a cause of heart failure. 1